Plasmodium knowlesi Duffy binding protein alpha region II (PkDBPαII) in clinical isolates from Peninsular Malaysia and Malaysian Borneo exhibit different immune responses in animal models
- PMID: 36152079
- DOI: 10.1007/s00436-022-07665-7
Plasmodium knowlesi Duffy binding protein alpha region II (PkDBPαII) in clinical isolates from Peninsular Malaysia and Malaysian Borneo exhibit different immune responses in animal models
Abstract
Plasmodium knowlesi utilizes the Duffy binding protein alpha (PkDBPα) to facilitate its invasion into human erythrocytes. PkDBPα region II (PkDBPαII) from Peninsular Malaysia and Malaysian Borneo has been shown to occur as distinct haplotypes, and the predominant haplotypes from these geographical areas demonstrated differences in binding activity to human erythrocytes in erythrocyte binding assays. This study aimed to determine the effects of genetic polymorphisms in PkDBPαII to immune responses in animal models. The recombinant PkDBPαII (~ 45 kDa) of Peninsular Malaysia (PkDBPαII-H) and Malaysian Borneo (PkDBPαII-S) were expressed in a bacterial expression system, purified, and used in mice and rabbit immunization. The profile of cytokines IL-1ra, IL-2, IL-6, IL-10, TNF-α, and IFN-γ in immunized mice spleen was determined via ELISA. The titer and IgG subtype distribution of raised antibodies was characterized. Immunized rabbit sera were purified and used to perform an in vitro merozoite invasion inhibition assay. The PkDBPαII-immunized mice sera of both groups showed high antibody titer and a similar IgG subtype distribution pattern: IgG2b > IgG1 > IgG2a > IgG3. The PkDBPαII-H group was shown to have higher IL-1ra (P = 0.141) and IL-6 (P = 0.049) concentrations, with IL-6 levels significantly higher than that of the PkDBPαII-S group (P ≤ 0.05). Merozoite invasion inhibition assay using purified anti-PkDBPαII antibodies showed a significantly higher inhibition rate in the PkDBPαII-H group than the PkDBPαII-S group (P ≤ 0.05). Besides, anti-PkDBPαII-H antibodies were able to exhibit inhibition activity at a lower concentration than anti-PkDBPαII-S antibodies. PkDBPαII was shown to be immunogenic, and the PkDBPαII haplotype from Peninsular Malaysia exhibited higher responses in cytokines IL-1ra and IL-6, antibody IgM level, and merozoite invasion inhibition assay than the Malaysian Borneo haplotype. This suggests that polymorphisms in the PkDBPαII affect the level of immune responses in the host.
Keywords: Genetic polymorphism; Immunogenicity; PkDBPαII protein; Plasmodium knowlesi.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Distinct genetic difference between the Duffy binding protein (PkDBPαII) of Plasmodium knowlesi clinical isolates from North Borneo and Peninsular Malaysia.Malar J. 2015 Feb 21;14:91. doi: 10.1186/s12936-015-0610-x. Malar J. 2015. PMID: 25890095 Free PMC article.
-
The Duffy binding protein (PkDBPαII) of Plasmodium knowlesi from Peninsular Malaysia and Malaysian Borneo show different binding activity level to human erythrocytes.Malar J. 2017 Aug 11;16(1):331. doi: 10.1186/s12936-017-1984-8. Malar J. 2017. PMID: 28800732 Free PMC article.
-
Two Genetically Distinct Plasmodium knowlesi Duffy Binding Protein Alpha Region II (PkDBPαII) Haplotypes Demonstrate Higher Binding Level to Fy(a+b+) Erythrocytes than Fy(a+b--) Erythrocytes.Am J Trop Med Hyg. 2020 May;102(5):1068-1071. doi: 10.4269/ajtmh.19-0836. Am J Trop Med Hyg. 2020. PMID: 32189613 Free PMC article.
-
Plasmodium knowlesi in travellers, update 2014.Int J Infect Dis. 2014 May;22:55-64. doi: 10.1016/j.ijid.2013.12.016. Epub 2014 Mar 12. Int J Infect Dis. 2014. PMID: 24631521 Review.
-
Plasmodium knowlesi: from Malaysia, a novel health care threat.Infez Med. 2012 Mar;20(1):5-11. Infez Med. 2012. PMID: 22475654 Review.
References
-
- Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, Aikawa M, Miller LH (1990) The duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63:141–153. https://doi.org/10.1016/0092-8674(90)90295-p - DOI - PubMed
-
- Angulo I, Fresno M (2002) Cytokines in the pathogenesis of and protection against malaria. Clin Diag Lab Immunol 9(6):1145–1152. https://doi.org/10.1128/CDLI.9.6.1145-1152.2002 - DOI
-
- Bachmann MF, Oxenius A (2007) Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep 8:1142–1148. https://doi.org/10.1038/sj.embor.7401099 - DOI - PubMed - PMC
-
- Berger A (2000) Science commentary - Th1 and Th2 responses: what are they? BMJ 321(7258):424. https://doi.org/10.1136/bmj.321.7258.424 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources